Psychiatrists rally to end stigma around psychedelic drugs

Stigma around psychedelic drugs is hampering research into their use for treating psychiatric disorders, say psychiatrists and advocates.

This is despite growing evidence in favour of their use for treating conditions such as PTSD, says Professor David Castle, chair of psychiatry at the University of Melbourne.

But the drugs are classified as schedule nine.